|Bid||0.3300 x 0|
|Ask||0.3300 x 0|
|Day's Range||0.2600 - 0.2600|
|52 Week Range||0.2600 - 0.2600|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Red White & Bloom Brands Inc. (CSE: RWB and OTC: TDRYD) (“RWB” or the “Company”) is pleased to announce that its investee PharmaCo Inc. continues to execute on their expansion, having been awarded nine (9) new Municipal Marijuana cultivation licenses in June and commencing their first harvest at their Detroit indoor cultivation facility. PharmaCo was awarded five (5) Municipal Class C grow licenses in Spaulding Township and four (4) Municipal Class C grow licenses in Au Gres Township; collectively this represents the right to grow 13,500 plants, subject to final State approvals.
Red White & Bloom Brands Inc. (CSE: RWB; OTCQX: TDRYD) (“RWB” or the “Company”), today announced that it has qualified to trade on the OTCQX® Best Market, operated by OTC Markets Group. RWB upgraded to OTCQX from the Pink® market. RWB begins trading today on OTCQX under the symbol “TDRYD.”
RWB secures exclusive licensing rights for High Times branded locations and product brands for Michigan, Illinois and Florida and Culture for CBD nationally in the U.S. Under the terms of the Definitive Agreement, RWB has acquired the rights to exclusively brand both medical and recreational dispensaries and cannabis products within the States of Michigan, Illinois and Florida.
The Company also reports that the current symbol “TDRYD” will remain in effect until or about July 1, 2020 at which point the new US trading symbol will be “RWBYF”. The Company is an investment company that is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector.
In connection with the Transaction, certain shareholders, including management and founders of the Company, entered into voluntary escrow and/or escrow and leak out agreements totaling 36,844,823 Common shares and 3,200,000 Options to purchase Common shares. Additionally, 108,726,349 Series II Preferred shares and Options to acquire 7,401,429 Series II Preferred shares are restricted for 7 months.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR DISSEMINATION IN THE UNITED STATES TORONTO, June 05, 2020 -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: TDRYD).
The Company is an investment company that is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector. When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR DISSEMINATION IN THE UNITED STATES TORONTO, June 05, 2020 -- Red White & Bloom Brands Inc..
Trading will resume under the new symbol “CSE: RWB” in Canada and under the symbol “OTC: RWBYF”in the United States. The Company has applied to trade on the OTCQX Best Market, a market designed for established, investor-focused U.S. and international companies. The Company will provide updates on the up-listing in the coming weeks.
As a result of the Transaction, the Company has changed its name to “Red White & Bloom Brands Inc.” and MichiCann is now a wholly-owned subsidiary of the Company. In connection with and immediately prior to the completion of the Transaction, the Company completed a share consolidation on a 16:1 basis.
Tidal Royalty Corp. (CSE: RLTY.U |OTC: TDRYF) (“Tidal” or the “Company”) is pleased to provide an update further to the executed business combination agreement with MichiCann Medical Inc. (operating as Red White & Bloom) (“MichiCann”) (see our news release dated May 13, 2019). On March 12, 2020, the Company and MichiCann entered into an amended and restated business combination agreement (the “Amended Agreement”) pursuant to which the Company will acquire all of the issued and outstanding shares of MichiCann (the “Proposed Transaction”) on a 2:1 basis, subject to adjustment in certain circumstances (the “Exchange Ratio”). The terms of the Amended Agreement provide that the share consideration will now be comprised of one (1) common share (the “Common Shares”) and one (1) series 2 convertible preferred share (the “Series 2 Shares”) of the resulting company (the “Resulting Issuer”).